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Abstract: Injection drug users engage in behaviors that increase the spread of human 
immunodeficiency virus (HIV) and other infectious diseases. Although methadone maintenance 
(MM) is highly effective in decreasing heroin use and the spread of HIV, polydrug use, especially 
the combined use of cocaine and alcohol, is common in MM patients. Alcohol use is indepen-
dently associated with HIV risk behaviors, and the effects of alcohol use on risk behaviors may 
vary by gender. This study evaluated the effects of recent heavy alcohol use and gender with 
respect to HIV risk behaviors in 118 cocaine-abusing methadone patients. Both lifetime and 
past month injection and sexual risk behaviors were examined. Recent heavy drinkers (n = 46) 
were more likely to be male than nonheavy drinkers (n = 72). Recent heavy drinkers reported 
more risky sexual behaviors over their lifetimes than nonheavy drinkers. Gender effects were 
also present for lifetime risk behaviors, with females demonstrating more sexual and injection 
risk behaviors than men. In terms of recent injection risk behaviors, there was a significant 
alcohol use by gender effect. Heavy drinking females reported significantly more drug-sharing 
behaviors and less frequent needle cleaning than nonheavy drinking females. Recent sexual 
behaviors did not differ based on alcohol use status or gender. These findings may inform HIV 
prevention strategies in cocaine-abusing MM patients, and they suggest that cocaine-abusing 
women who drink heavily are a particularly high risk group who should be counseled about 
risky injection drug use practices.
Keywords: HIV risk behaviors scale, gender, alcohol use, methadone maintenance, opioid 
dependence, cocaine use
Introduction
Injection drug users and their sexual partners are at great risk of contracting and 
spreading human immunodeficiency virus (HIV). Drug abuse treatment, and especially 
methadone maintenance (MM), is highly effective in decreasing opioid use.1 MM treat-
ments have been highlighted as an effective HIV prevention and risk reduction strategy.2 
However, not all patients respond well to this intervention, and many continue using 
opioids as well as other drugs while maintained on methadone. Up to 50% of MM 
patients abuse cocaine,3,4 and cocaine use in MM patients is related to increased HIV 
risk-taking behaviors. Compared to their noncocaine-using counterparts, MM patients 
who abuse cocaine are more likely to inject drugs, share needles, have high numbers 
of sexual partners, and pay for or receive payment for sex.5–8 Thus, cocaine-abusing 
MM patients are an important population for studying HIV risk behaviors.
Cocaine and alcohol use are a highly prevalent polysubstance use combination. 
Estimates indicate that 52%–61% of cocaine abusers also have problems with alcohol,9,10 
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and in MM populations, 41%–52% also drink excessively.11,12 
As reviewed below, alcohol use is independently associated 
with HIV risk behaviors, and alcohol use among cocaine-
abusing MM patients may exacerbate HIV risk behaviors in 
this particularly high-risk population.
Alcohol use is related to risky sexual activities. Among 
cocaine-using MM patients, past month heavy alcohol use is 
associated with more HIV risk related to number of sexual 
partners, drug-injecting and needle-sharing sexual partners, 
and trading sex for money or drugs.13 In a large sample of 
injection drug users, Arasteh and colleagues14 examined 
drinking patterns along with risky sexual activities over 
the past six months. Heavy drinkers reported more sexual 
partners and unprotected sex with casual partners than 
moderate drinkers or nondrinkers. Further, injection drug 
users reported same-day temporal associations between 
alcohol use and unprotected sexual encounters,14,15 suggesting 
alcohol use may be involved in decisions to not use condoms. 
Injection drug users reporting alcohol intoxication in the 
past 30 days have an eightfold and sixfold increase in the 
likelihood of having sex with a paying partner and trading 
sex for drugs or money, respectively.16
Because trading sex for drugs or money occurs more often 
among female substance abusers,17 gender effects may be an 
important consideration for understanding the interaction of 
alcohol use and sexual risk behaviors. Rees and colleagues18 
reported a significant alcohol use by gender interaction for 
risky sexual activities among injection drug users; males and 
females with low levels of alcohol consumption had similar 
levels of sexual risk-taking, but females with high levels of 
alcohol use reported more sexual risk-taking than males who 
drank frequently.
Evidence relating alcohol use and drug-related risk 
behaviors is more mixed. For example, Rees and colleagues18 
noted no association between alcohol use and risky injection 
drug use behaviors, but Matos and colleagues16 found that 
those who reported drinking to intoxication in the past month 
injected drugs more frequently and were more likely to share 
injecting equipment than those without recent alcohol use 
to intoxication. In samples from a needle exchange program, 
alcohol use was associated with greater needle-sharing 
behaviors, both in overall risk level19 and in same-day needle-
sharing risk.20 These patients used injection equipment after 
someone else 1.5 times more often on days in which they 
drank compared to nondrinking days. Gender was unrelated to 
overall drug HIV risk-taking18 or needle-sharing risks.19,20
The purpose of this study was to further characterize 
the association between alcohol use and HIV risk behaviors 
in cocaine-abusing methadone patients. We hypothesized 
that heavy alcohol use would be associated with greater 
sex-related HIV risk-taking and possibly drug use HIV risk 
behaviors. Because of the impact of gender on sex-related 
HIV risk behaviors, our analyses also examined main and 
interaction effects of gender.
Method
Participants
Participants for this study were drawn from two randomized 
clinical treatment trials.21,22 Both trials recruited cocaine-
abusing methadone patients, were conducted in the same 
methadone clinic, and involved randomization to standard 
care plus frequent urine monitoring or the same standard 
care plus contingency management, in which patients earned 
the chance to win prizes for submission of drug-negative 
samples. Study treatment details are not provided here as 
these analyses concern data collected at the intake session 
only; full descriptions of treatment conditions and outcomes 
are available from the primary reports.21,22
For both trials, inclusion criteria were a) a stable metha-
done dose (no changes in the past three months), b) English-
speaking, and c) ability to comprehend study procedures 
(eg, no severe dementia). Both studies excluded individuals 
with active, uncontrolled psychosis, bipolar disorder or 
suicidality. Participants provided informed consent, approved 
by the university’s institutional review board. No differences 
between the studies were present for recent alcohol use or 
lifetime or recent HIV risk behaviors (P  0.05; data not 
shown). In addition, participants in the two studies did not 
differ by age, gender, race, marital status, employment status, 
years of education, past year income, methadone dose, and 
years of cocaine, alcohol, or opioid use (all P  0.05; data 
not shown). Because of the similarities across studies and 
samples, the two trials were combined for analysis to increase 
power to ascertain main and interactive effects of alcohol use 
and gender on HIV risk behaviors.
A total of 119 participants were enrolled in the studies.21,22 
We categorized participants based on recent heavy alcohol 
use, defined as self report of at least one episode of drinking 
to intoxication in the 30 days prior to the intake assess-
ment. One individual had missing alcohol use data and was 
excluded from the analyses, leaving a final sample size of 
118 for these analyses.
Table 1 presents demographic and baseline comparisons 
between the drinking groups. Heavy drinking cocaine-abus-
ing methadone patients (n = 46) were more likely to be 
male, had more years of alcohol use and years of drinking 
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to intoxication, and reported more days of alcohol use in the 
past month compared to those without recent heavy drinking 
episodes (n = 72).
Measures and procedure
At study intake, research assistants administered lifetime 
and past month versions of the HIV Risk-taking Behavior 
Scale (HRBS).23 The HRBS assesses 11 HIV risk-taking 
behaviors in two domains, drug injecting and sexual. 
Each item has five response categories, which were scored 
from 0–5, with higher values indicating greater risk. Drug and 
sex subscale scores range from 0–30 and 0–25, respectively. 
The psychometric properties of this scale are well defined,23–25 
and collateral agreement with sexual partners is high.26
Table 1 Descriptive characteristics of cocaine-abusing methadone patients with and without recent heavy alcohol use
Descriptive variables Recent heavy alcohol use 
(n = 46)
No recent heavy alcohol use  
(n = 72)
Test statistic  
(d.f.)
P 
% Randomized to cM 44 53 X2(1) = 0.97 0.32
study (%) X2(1)  = 0.15 0.70
 Petry and Martin (2002) 36 33
 Petry and colleagues (2005) 64 67
ethnicity (%) X2(2)  = 2.41 0.30
 Hispanic 54 43
 African American 35 36
 caucasian 11 21
% Female 57 83 X2(1)  = 10.21 0.001
% Never married 72 64 X2(1)  = 0.78 0.38
% Unemployed or disabled 57 64 X2(1)  = 0.64 0.42
% cocaine positive at intake 67 63 X2(1)  = 0.29 0.59
% Opiate positive at intake 30 31 X2(1)  = 0.01 0.99
Mean ± SD
Age 38.33 ± 6.10 39.60 ± 6.23 t(116)  = 1.09 0.28
education 10.51 ± 1.98 11.15 ± 2.01 t(116)  = 1.68 0.10
Past year income $8750 ± $10800 $8700 ± $7750 t(111)  = -0.03 0.98
Methadone dose 71.67 ±  27.54 74.14 ± 32.74 t(115)  = 0.42 0.67
Days of substance use in past month
 Drinking (any amount) 8.02 ± 9.53 0.38 ± 1.09 t(46)  = -5.42 0.001
 Drinking to intoxication 6.57 ± 9.53 0.00 ± 0.00 t(45)  = -5.10 0.001
 Heroin 1.91 ± 3.52 1.36 ± 3.81 t(116)  = -0.79 0.43
 cocaine 11.17 ± 10.52 7.36 ± 9.76 t(116)  = -2.01 0.05
 Marijuana 2.46 ± 6.35 0.93 ± 4.97 t(116)  = -1.46 0.15
 Benzodiazepine 0.09 ± 0.35 0.11 ± 0.46 t(116)  = 0.30 0.76
Years of substance use
 Drinking (any amount) 19.43 ± 9.42 9.25 ± 10.79 t(116)  = -5.25 0.001
 Drinking to intoxication 12.54 ± 8.66 2.84 ± 5.02 t(64)  = -6.89 0.001
 Heroin 14.57 ± 8.15 16.85 ± 8.69 t(116)  = 1.43 0.16
 cocaine 13.35 ± 7.48 12.83 ± 8.23 t(116)  = -0.35 0.73
Lifetime treatment attempts for
  Alcohol 2.04 ± 6.10 0.18 ± 0.57 t(45)  = -2.07 0.05
 cocaine 3.07 ± 6.91 2.47 ± 5.30 t(116) = -0.53 0.60
 Opiates 8.46 ± 8.92 8.17 ± 5.62 t(68)  = -0.20 0.84
Notes: Fluctuations in t-test degrees of freedom reflect use of corrected statistics for variance heterogeneity. Lifetime treatment attempts include detoxification.
Abbreviations: cM, contingency management; sD, standard deviation.
Neurobehavioral HIV Medicine 2009:128
Rash and Petry Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
The Addiction Severity Index (ASI)27 assessed demographics, 
substance use history, and prior treatment attempts. Research 
assistants collected urine samples at study intake using Ontrak 
Teststicks (Roche, Somersville, NJ, USA) to screen for opioids 
and cocaine.
statistical analyses
We compared sample characteristics of the recent heavy 
alcohol use groups (recent heavy drinking versus no recent 
heavy drinking) using t-tests and χ2 tests of independence. 
The alcohol use groups differed with respect to gender, 
and because gender is associated with some HIV risk 
behaviors,3,17,28 all subsequent analyses included gender as 
an independent variable.
To assess the impact of recent heavy alcohol use and 
gender on HIV risk behaviors, we examined the HRBS sex 
and drug subscales using univariate analyses of variance 
(ANOVA) for both lifetime and past month versions of 
the scale. Alcohol use group and gender were independent 
variables in the analyses. To account for potential age-related 
sources of variation as older individuals have more years to 
participate in more risky behaviors, ANOVAs were weighted 
by age using the weighted least squares procedure.
Following the examination of the sex and drug subscale 
scores, we investigated responses to individual HRBS items 
for lifetime and past month behavior. For each HRBS item, 
we examined the sample’s response distribution according 
to recent heavy alcohol use status within each gender using 
χ2 tests of independence. The distribution of responses was 
not uniform, with some categories rarely endorsed by partici-
pants, and was sparse overall due to the nesting of analyses 
within gender. To account for these distributional limitations, 
exact P-values were calculated.
Results
subscale-level analyses
Table 2 presents average age-weighted HRBS drug and sex 
subscale scores by recent heavy alcohol use groups and 
gender. Both lifetime and past month risk-taking scores are 
presented.
Lifetime behaviors
Significant effects of gender were present for the lifetime 
drug behavior subscale, F(1, 108)  = 4.40, P = 0.04, with 
females (M  = 13.49, SE = 0.89) reporting more risk behaviors 
compared to males (M = 10.07, SE = 1.37). Neither the 
main effect of heavy alcohol use group, F(1, 108)  = 0.78, 
P = 0.38, nor the interaction of recent heavy alcohol use group 
and gender, F(1, 108)  = 1.49, P = 0.23, were statistically 
significant for drug use behavior.
For the sex-related behavior subscale, main effects 
for recent heavy alcohol use group and gender were both 
significant. Participants with recent heavy drinking episodes 
(M = 10.51, SE = 0.55) reported significantly higher levels of 
lifetime sex-related risk behaviors compared to individuals 
without recent heavy drinking (M = 8.68, SE = 0.57), 
F(1, 108)  = 5.38, P = 0.02. Women (M = 10.39, SE = 0.43) 
reported greater risky sexual behaviors over their lifetimes 
than men (M = 8.80, SE = 0.67), F(1, 108)  = 4.00, P = 0.048. 
The interaction of gender and recent heavy alcohol use groups 
was not significant, F(1, 108)  = 0.78, P = 0.38.
Past month behaviors
For past month drug-related risk behaviors, main effects 
of alcohol use group and gender were not significant, 
F(1, 108)  = 0.41, P = 0.84, and F(1, 108)  = 0.24, P = 0.62, 
respectively. However, a significant interaction effect was 
Table 2 Lifetime and past month HRBs drug and sex subscale scores by alcohol use group and gender
HRBS subscales Females Males P-values
Recent heavy  
alcohol use  
(n = 26)
No recent  
heavy alcohol  
use (n = 56)
Recent heavy  
alcohol use  
(n = 19)
No recent  
heavy alcohol  








Drug-related 13.77 (1.46) 13.22 (1.02) 8.36 (1.71) 11.79 (2.13) 0.38 0.04 0.23
sex-related 11.66 (0.71) 9.12 (0.50) 9.37 (0.83) 8.23 (1.04) 0.02 0.048 0.38
Past month behaviors
Drug-related 3.29 (0.69) 1.00 (0.45) 1.22 (0.79) 3.82 (1.02) 0.84 0.62 0.002
sex-related 3.69 (0.68) 1.90 (0.45) 3.61 (0.79) 3.64 (1.02) 0.25 0.28 0.24
Notes:  Values represent age-adjusted means (standard errors) unless otherwise noted. Recent heavy drinking defined as 1 episode of drinking to intoxication in the past 
30 days.
Abbreviations: HIV, human immunodeficiency virus; HRBS, HIV risk-taking behavior scale.
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present, F(1, 108)  = 10.23, P = 0.002. As shown in Table 2, 
males without a recent heavy drinking episode reported more 
recent risky drug using behaviors than males with a recent 
heavy drinking episode. For females, the pattern was reversed, 
such that heavy drinking was associated with greater drug 
risk-taking behaviors, whereas females without recent heavy 
drinking reported fewer risky injection drug use behaviors 
in the prior month.
For past month sexual behaviors, neither the main effects, 
nor the interaction of alcohol use group and gender were 
significant: alcohol: F(1, 108)  = 1.33, P = 0.25, gender: 
F(1, 108)  = 1.19, P = 0.28, and interaction: F(1, 108) = 1.42, 
P = 0.24.
Item-level analyses
Table 3 presents the percentage of participants endorsing 
specified risk levels for each item of the HRBS. Each item 
had a five-point response category, but we present percent-
ages dichotomized by high-risk responses and low-risk 
responses for each item in order to condense information. 
The actual responses for each item are detailed in the table, 
along with how percentages were dichotomized for illustra-
tive purposes. The data are presented separately for males 
and females with and without recent heavy alcohol use. The 
right-hand columns in the table present significance levels 
when comparing alcohol use groups within genders.
Lifetime HIV risk behaviors
Males with and without recent heavy alcohol use differed 
on only one lifetime risk behavior. All of the males without 
recent heavy drinking reported regular drug injecting 
behaviors in their lifetimes, while 32% of males with heavy 
drinking episodes indicated they never injected regularly, 
X2(2, 31) = 6.81, P = 0.03.
Females with and without recent heavy alcohol use did 
not differ with respect to any of the lifetime drug use risk 
behaviors, but one lifetime sexual risk behavior differed 
based on alcohol use status. Females with recent heavy 
alcohol use were more likely to have engaged in paid sexual 
activities (with or without condoms) than females without 
recent heavy alcohol use, χ2(5, 82) = 12.08, P = 0.02. Nonsig-
nificant trends toward higher rates of other lifetime sexual risk 
behaviors (condom nonuse with casual partners and anal sex) 
were also noted among females with heavy alcohol use.
Past month HIV risk behaviors
Males did not demonstrate any significant differences with 
respect to recent drug use or sexual risk behaviors based 
on alcohol use status. However, a number of significant 
differences between alcohol use groups were present for 
females for drug-related risk behaviors in the past month. 
Females with recent heavy drinking were significantly more 
likely than their counterparts who did not drink heavily to 
report using needles after someone else, χ2(4, 82) = 9.21, 
P = 0.03. Females who drank heavily in the past month also 
reported using needles after a greater number of other people 
than females who had not drank heavily in the past month, 
X2(2, 82) = 8.325, P = 0.01.The female alcohol use groups 
also differed significantly with respect to the frequency of 
cleaning needles, X2(4, 82) = 13.38, P = 0.002, and using 
bleach to clean needles X2(4, 82) = 17.10, P = 0.001. Again, 
females with recent heavy alcohol use endorsed higher 
levels of risk behaviors in these domains than females 
without recent heavy alcohol use.
Discussion
The results of this study suggest that recent heavy alcohol 
use patterns of MM patients may be an indicator for targeted 
intervention of HIV risk-taking behaviors. Cocaine-abusing 
MM patients with recent heavy drinking reported more life-
time sexual risk-taking compared to those without recent 
heavy drinking. Recent heavy alcohol use was also associated 
with more past month drug-related risk-taking; however, this 
effect was limited to females. Gender effects were noted 
for both drug and sexual lifetime behaviors, with females 
reporting more risk-taking compared to males. These find-
ings underscore the importance of gender in understanding 
the impact of alcohol use on HIV risk-taking in cocaine-
abusing MM patients. We found main effects of gender on 
lifetime (but not recent) sexual and drug use risk behaviors. 
Some other reports also note that women substance abusers 
engage in higher risk-taking behaviors than their male 
counterparts,3,26 but others do not find such associations.19,20 
The reasons for these discrepant findings are unclear, but 
they may relate to the manner and types of risk behaviors 
assessed, the sample sizes included, the time period over 
which risk behaviors are assessed, or the population studied. 
A recent study by Cavazos-Rehg and colleagues29 suggests 
that sexual risk-taking profiles differ by gender across several 
samples (cocaine-dependent treatment seekers, community-
matched cocaine-dependent peers, community-matched 
experimental cocaine users, and community-matched never-
users of cocaine).
Our results also confirm and extend prior findings 
regarding the role of alcohol use in HIV risk behaviors. 
Several studies have linked heavy alcohol use to sexual 
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Injected drugs one time/week, 2–6 times/week, one 
time/day, 2–3 times/day or three times/day (vs never)
88 91 68 100 0.88 0.03
Used needles after someone else one, two, 3–5, 6–10, 
or 10 times (vs never shared)
77 58 32 42 0.47 1.00
One, two, 3–5, 6–10, or 10 persons used needles 
before you (vs 0)
73 58 35 42 0.37 0.50
someone used needles after you 1, 2, 3–5, 6–10, 
or 10 times (vs 0)
73 66 53 42 0.83 0.91
cleaned needles every time, often, sometimes, rarely, 
or never (vs does not reuse)
88 82 58 83 0.61 0.38
cleaned needles with bleach every time, often, 
sometimes, rarely, or never (vs does not reuse)
88 82 58 83 0.94 0.33
Lifetime sex-related behaviors
11–30, 31–50, or 50 sexual partners (vs 0, 1, or 2–10) 50 33 16 50 0.44 0.08
condom with regular partners often, sometimes, rarely, 
or never (vs every time or no regular partner) 
96 96 84 92 0.45 0.27
condom with casual partners often, sometimes, rarely, 
or never (vs every time or no casual partners)
42 35 32 25 0.08 0.19
condom for paid sex every time, often, sometimes, 
rarely, or never (vs no paid sex)
73 44 37 17 0.02 0.75
Had anal sex one, two, 3–5, 6–10, or 10 times (vs never) 58 33 32 8 0.09 0.33
Past month drug-related behaviors
Injected drugs one time/week, 2–6 times/week, one 
time/day, 2–3 times/day or 3 times/day (vs never)
42 21 32 58 0.12 0.25
Used needles after someone else 1, 2, 3–5, 6–10, 
or 10 times (vs never shared)
23 4 0 0 0.03 –
One, two, 3–5, 6–10, or 10 persons used needles 
before you (vs 0)
19 4 0 0 0.01 –
someone used needles after you one, two, 3–5, 6–10, 
or 10 times (vs 0)
15 4 0 0 0.07 –
cleaned needles every time, often, sometimes, rarely, 
or never (vs does not reuse)
31 9 16 42 0.002 0.08
cleaned needles with bleach every time, often, 
sometimes, rarely, or never (vs does not reuse)
31 9 16 42 0.001 0.23
Past month sex-related behaviors
Two, 3–5, 6–10, or 10 sexual partners (vs 0 or 1) 15 4 16 0 0.21 0.15
condom with regular partners often, sometimes, rarely, 
or never (vs every time or no regular partner) 
46 27 53 67 0.14 0.16
condom with casual partners often, sometimes, rarely, 
or never (vs every time or no casual partners)
12 5 11 0 0.40 1.00
condom for paid sex every time, often, sometimes, 
rarely, or never (vs no paid sex)
11 2 5 0 0.09 1.00
Had anal sex one, two, 3–5, 6–10, or 10 times (vs never) 4 5 5 0 0.81 1.00
Notes: Provided P-values correspond to the exact significance value of chi-squared tests of independence examining effects of alcohol use category within each gender using 
all response categories. For brevity, we provide collapsed percentages for the participants endorsing specified levels (eg,  1 time, often or less frequently) of risk behavior.
Abbreviations: HIV, human immunodeficiency virus; HRBS, HIV risk-taking behavior scale.
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risk-taking behaviors.13,14,16 Similarly, participants with 
recent heavy drinking in our study had higher overall life-
time sexual risk behaviors than those who were not recent 
heavy drinkers.
The interaction between alcohol use and gender noted in 
this study is similar to that reported by Rees and colleagues.18 
Recent heavy alcohol use in females was associated with more 
drug-related risk-taking compared to females without recent 
heavy drinking. The relation between recent heavy drinking 
and drug-related risk behaviors appears to function differently 
among males, with recent heavy drinkers reporting less drug-
related HIV risk-taking than their nonheavy drinking male 
counterparts. Differing alcohol use motives (eg, drinking to 
cope versus drinking in place of using drugs) and/or temporal 
drinking patterns (eg, drinking before drug-using situations) 
between genders may contribute to such different effects 
between alcohol and risk-taking. Few other studies have exam-
ined gender effects together with alcohol use patterns in under-
standing HIV risk behaviors (see Randolph and colleagues30 
for an examination of gender, alcohol use and expectancies, 
and sexual risk-taking in a college sample). Our results in 
conjunction with those of Rees and colleagues18 suggest 
gender is an important factor for understanding the impact of 
alcohol on both sexual and drug-taking risk behaviors.
The item-level analyses suggest specific areas to target for 
HIV risk reduction, especially ongoing intravenous injection 
behaviors in heavy drinking cocaine-abusing female MM 
patients. Females with recent heavy alcohol use endorsed 
higher risk levels on items related to using needles after 
someone else, using needles after multiple other persons, 
needle cleaning, and use of bleach for cleaning needles. Our 
findings highlight specific subgroups of the cocaine-abusing 
MM population (eg, females with recent heavy alcohol use) 
and specific behaviors to address in HIV risk interventions. 
However, we note that HIV risk-taking levels were high for 
the entire sample, and our findings do not negate the need for 
HIV risk education for all cocaine-abusing MM patients.
Strengths of the current study include the use of a 
particularly high-risk population (ie, polydrug-abusing MM 
patients) and the assessment of both lifetime and recent risk 
behaviors. HIV risk reduction is an important and timely 
topic for the MM population. Our results suggest that even 
relatively low levels of alcohol problems (1 episode 
of intoxication in past 30 days) can be a useful indicator 
for understanding and intervening in HIV risk behaviors, 
particularly when gender is also considered.
Study limitations include use of self-reported HIV 
risk behaviors and past month alcohol use patterns. 
However, Darke31 suggests that both drug use self-reports 
and HIV risk-taking self-reports by injection drug users 
and MM patients are consistently reliable and valid across a 
number of studies when confidentiality of the participants’ 
self-report is ensured, a practice employed in the current study. 
Because HIV status was not assessed in this study, we are 
unable to relate the impact of infection on risk behaviors.
Cocaine-abusing MM patients represent a substantial 
portion (∼50%) of the MM patient base. Research suggests 
that cocaine use during MM treatment often remains 
unchanged, even when other drug use decreases.32,33 Given 
evidence that cocaine use during MM treatment negatively 
impacts treatment outcomes (eg, heroin use) and is associ-
ated with continuation of high risk behaviors (eg, injection, 
needle-sharing),33 the cocaine-using MM population war-
rants additional attention from clinicians. Results from this 
study provide additional information for clinicians to tailor 
targeted interventions for HIV risk reduction to specific risk 
areas given alcohol use status and gender.
Involvement in MM programs provides an ideal oppor-
tunity for HIV risk reduction efforts, and a substantial 
amount of research suggests that such harm reduction efforts 
are effective in reducing risk behaviors.2,3,13,34,35 Although 
polydrug-abusing MM patients present significant chal-
lenges to treatment efforts, data suggest HIV risk reduction is 
possible even among patients who continue abusing cocaine 
during MM treatment.13 Results of the present study provide 
further characterization of the effects of alcohol use and 
gender on HIV risk behaviors among cocaine-abusing MM 
patients and suggest areas of focus for HIV risk reduction 
efforts within this high-risk population.
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